tiprankstipranks
Trending News
More News >
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market

Skye Bioscience (SKYE) Financial Statements

Compare
936 Followers

Skye Bioscience Financial Overview

Skye Bioscience's market cap is currently $32.70M. The company's EPS TTM is $-0.32; its P/E ratio is -0.79; Skye Bioscience is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ -1.87K
Operating Income$ -30.19M$ -34.74M$ -18.31M$ -7.85M$ -6.29M
EBITDA$ -25.29M$ -36.62M$ -18.70M$ -7.72M$ -5.85M
Net Income$ -26.57M$ -37.64M$ -19.48M$ -8.52M$ -6.56M
Balance Sheet
Cash & Short-Term Investments$ 68.42M$ 1.26M$ 1.24M$ 8.98M$ 2.47M
Total Assets$ 72.76M$ 11.94M$ 9.11M$ 9.86M$ 2.67M
Total Debt$ 455.59K$ 4.62M$ 1.98M$ 2.14M$ 1.50M
Net Debt$ -67.96M$ 3.36M$ 738.00K$ -6.85M$ -971.61K
Total Liabilities$ 4.61M$ 14.07M$ 12.12M$ 3.99M$ 2.22M
Stockholders' Equity$ 68.15M$ -2.13M$ -3.01M$ 5.86M$ 450.79K
Cash Flow
Free Cash Flow$ -26.84M$ -13.96M$ -12.77M$ -6.57M$ -6.06M
Operating Cash Flow$ -25.24M$ -13.95M$ -12.74M$ -6.47M$ -6.05M
Investing Cash Flow$ -245.62K$ 6.60M$ 5.21M$ -90.87K$ -7.23K
Financing Cash Flow$ 83.56M$ 16.44M$ -208.79K$ 13.08M$ 6.70M
Currency in USD

Skye Bioscience Earnings and Revenue History

Skye Bioscience Debt to Assets

Skye Bioscience Cash Flow

Skye Bioscience Forecast EPS vs Actual EPS